Passive Immunity

RAMAT GAN, Israel, Aug. 3, 2026 Can-Fite BioPharma Ltd. has launched its first clinical development program evaluating Piclidenoson for...

RESEARCH TRIANGLE PARK, N.C., Aug. 3, 2026 Opus Genetics, Inc. has completed patient enrollment in its registrational Phase 3...

BERKELEY HEIGHTS, N.J., Aug. 3, 2026 Tonix Pharmaceuticals Holding Corp. announced that it has received official Type C meeting...